ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $137,923 | +12.8% | 52,844 | +54.7% | 0.00% | – |
Q2 2023 | $122,311 | -77.0% | 34,165 | -70.6% | 0.00% | -100.0% |
Q2 2022 | $532,000 | -5.5% | 116,065 | +194.3% | 0.00% | +200.0% |
Q4 2021 | $563,000 | +336.4% | 39,433 | +29.6% | 0.00% | 0.0% |
Q4 2020 | $129,000 | +81.7% | 30,427 | +109.8% | 0.00% | 0.0% |
Q3 2018 | $71,000 | – | 14,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |